⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Evonik Industries AG and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Evonik Industries AG
↗Essen, Germany
Evonik Industries AG is a global leader in specialty chemicals, headquartered in Essen, Germany. The company operates in over 100 countries and focuses on delivering innovative, sustainable solutions across various sectors, including healthcare, automotive, electronics, and nutrition.
Evonik is organized into segments including Advanced Technologies and Custom Solutions, with a strong emphasis on biotechnology, high-performance polymers, and drug delivery technologies. As a major CDMO (Contract Development and Manufacturing Organization), Evonik supports the pharmaceutical industry with lipid excipients, LNP formulation services, and advanced manufacturing capabilities for biopharmaceuticals.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:
Industry:CDMO
Sub-Industry:Specialty Chemicals & Pharmaceutical Services
SIZE & FINANCIALS
Employees:10000+
Revenue:$14B-$16B
Founded:2007
Ownership:public
Status:operating
STOCK
Exchange:ETR
Ticker:EVK
Market Cap:$9.5B
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (CDMO focus)
Modalities:Small molecule, mRNA, Lipid Nanoparticles (LNP)
Active Trials:11
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Ethris (Nucleic acid delivery platforms/LNP technology), Higuchi Inc. (Oral drug delivery innovation)
COMPETITION
Position:Leader
Competitors:Arkema, Clariant, Lonza, PPG Industries
LEADERSHIP
Key Executives:
Christian Kullmann - CEO
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Evonik Industries AG. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.